The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels

European Journal of Pharmacology

Volumn 634, Issue 1-3, 2010, Pages 10-15

  Alptekin, Alp ^a   Galadari, Sehammuddin ^b   Shuba, Yaroslav ^c   Petroianu, Georg ^b   Oz, Murat ^b,d  

^a Yildirim Beyazit Training and Research Hospital   (Turkey)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

AM404; Calcium channel; Endocannabinoid; Skeletal muscle

Indexed keywords

ARACHIDONIC ACID; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; ISRADIPINE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; VOLTAGE DEPENDENT ANION CHANNEL; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; ENDOCANNABINOID; N-(4-HYDROXYPHENYL)ARACHIDONYLAMIDE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG PROTEIN BINDING; IC 50; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; RABBIT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELLS, CULTURED; MUSCLE, SKELETAL; POLYUNSATURATED ALKAMIDES; PROTEIN BINDING; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; ENDOCANNABINOIDS;

EID: 77951207479     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.013     Document Type: Article

References (32)

1. Boland L.M., Drzewiecki M.M. Polyunsaturated fatty acid modulation of voltage-gated ion channels. Cell Biochem. Biophys. 2008, 52:59-84.
2. Caballero F.J., Navarrete C.M., Hess S., Fiebich B.L., Appendino G., Macho A., Muñoz E., Sancho R. The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events. Biochem. Pharmacol. 2007, 73:1013-1023.
3. Cavuoto P., McAinch A.J., Hatzinikolas G., Janovská A., Game P., Wittert G.A. The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochem. Biophys. Res. Commun. 2007, 364:105-110.
4. Chang H.T., Huang C.C., Cheng H.H., Wang J.L., Lin K.L., Hsu P.T., Tsai J.Y., Liao W.C., Lu Y.C., Huang J.K., Jan C.R. Mechanisms of AM404-induced [Ca(2+)](i) rise and death in human osteosarcoma cells. Toxicol. Lett. 2008, 179:53-58.
5. Chemin J., Monteil A., Perez-Reyes E., Nargeot J., Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J. 2001, 20:7033-7040.
6. Chen W.C., Huang J.K., Cheng J.S., Tsai J.C., Chiang A.J., Chou K.J., Liu C.P., Jan C.R. AM-404 elevates renal intracellular Ca(2+), questioning its selectivity as a pharmacological tool for investigating the anandamide transporter. J. Pharmacol. Toxicol. Methods 2001, 45:195-198.
7. Cippitelli A., Bilbao A., Gorriti M.A., Navarro M., Massi M., Piomelli D., Ciccocioppo R., Rodríguez de Fonseca F. The anandamide transport inhibitor AM404 reduces ethanol self-administration. Eur. J. NeuroSci. 2007, 26:476-486.
8. 2+ channel activator (Bay K8644) and inhibitor (PN 200-110). Proc. Natl. Acad. Sci. U. S. A. 1986, 83:1518-15122.
9. Cognard C., Constantin B., Rivet-Bastide M., Imbert N., Besse C., Raymond G. Appearance and evolution of calcium currents and contraction during the early post-fusional stages of rat skeletal muscle cells developing in primary culture. Development 1993, 117:1153-1161.
10. De Lago E., Gustafsson S.B., Fernández-Ruiz J., Nilsson J., Jacobsson S.O., Fowler C.J. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. J. Neurochem. 2006, 99:677-688.
11. De Petrocellis L., Bisogno T., Davis J.B., Pertwee R.G., Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 2000, 483:52-56.
12. Di Marzo V. Endocannabinoids: synthesis and degradation. Rev. Physiol. Biochem. Pharmacol. 2008, 160:1-24.
13. Dunn S.M.J. Voltage-dependent calcium channels in skeletal muscle transverse tubules: measurements of calcium efflux in membrane vesicles. J. Biol. Chem. 1989, 264:11053-11060.
14. Flockerzi V., Oeken H.J., Hofmann F., Pelzer D., Cavalie A., Trautwein W. Purified dihydropyridine-binding site from skeletal muscle T-tubules is a functional channel. Nature 1986, 323:66-68.
15. Fowler C.J. "The tools of the trade" - an overview of the pharmacology of the endocannabinoid system. Curr. Pharm. Des. 2008, 14:2254-2265.
16. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
17. Jonsson K.O., Andersson A., Jacobsson S.O., Vandevoorde S., Lambert D.M., Fowler C.J. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide. Arch. Toxicol. 2003, 77:201-207.
18. Kelley B.G., Thayer S.A. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur. J. Pharmacol. 2004, 496:33-39.
19. Khanolkar A.D., Abadji V., Lin S., Hill W.A.G., Taha G., Abouzid K., Meng Z., Fan P., Makriyannis A. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. J. Med. Chem 1996, 39:4515-4519.
20. Neville C., Rosenthal N., McGrew M., Bogdanova N., Hauschka S. Skeletal muscle cultures. Methods in muscle biology 1997, 85-116. Academic Press, San Diego. C.P. Emerson, H.L. Sweeney (Eds.).
21. Nicholson R.A., Liao C., Zheng J., David L.S., Coyne L., Errington A.C., Singh G., Lees G. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res. 2003, 978:194-204.
22. Oz M. Receptor-independent effects of endocannabinoids on ion channels. Curr. Pharm. Des 2006, 12:227-239.
23. Oz M., Frank G.B., Dunn S.M.J. Voltage-Dependent Calcium Flux Across Rabbit Skeletal Muscle Transverse Tubule Membranes in the Range of Late After Potentials. Can. J. Pharmacol. Physiol. 1993, 71:518-521.
24. 2+ sensors. Mol. Pharmacol. 1998, 54:1106-1112.
25. Oz M., Tchugunova Y., Dunn S.M.J. Endogenous cannabinoid anandamide directly inhibits voltage-dependent calcium fluxes in rabbit T-tubule membrane preparations. Eur. J. Pharmacol. 2000, 404:13-20.
26. Oz M., Tchugunova Y., Dinc M. Differential effects of endocannabinoids and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit t-tubule membranes; comparison with fatty acids. Eur. J. Pharmacol. 2004, 502:47-58.
27. Oz M., Alptekin A., Tchugunova Y., Dinc M. Effects of saturated long-chain N-acylethanolamines voltage-dependent calcium fluxes in rabbit t-tubule membranes. Arch. Biochem. Biophys. 2005, 434:344-351.
28. 2+ channel expression in rat skeletal muscle cells. Pflugers Arch. 1999, 438:649-655.
29. 2+ channels by lipids. Cell Calcium 2009, 45:589-601.
30. 2+ channel inactivation. J. Biol. Chem. 1998, 273:957-963.
31. Trezza V., Vanderschuren L.J. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats. J. Pharmacol. Exp. Ther. 2009, 328:343-350.
32. Zygmunt P.M., Chuang H., Movahed P., Julius D., Högestätt E.D. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur. J. Pharmacol. 2000, 396:39-42.